197 related articles for article (PubMed ID: 20544194)
1. Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride.
Stauss J; Hahn K; Mann M; De Palma D
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1621-8. PubMed ID: 20544194
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
3. SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0.
Segall G; Delbeke D; Stabin MG; Even-Sapir E; Fair J; Sajdak R; Smith GT;
J Nucl Med; 2010 Nov; 51(11):1813-20. PubMed ID: 21051652
[No Abstract] [Full Text] [Related]
4. Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?
Ohnona J; Michaud L; Balogova S; Paycha F; Nataf V; Chauchat P; Talbot JN; Kerrou K
Nucl Med Commun; 2013 May; 34(5):417-25. PubMed ID: 23470463
[TBL] [Abstract][Full Text] [Related]
5. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate.
Blake GM; Park-Holohan SJ; Cook GJ; Fogelman I
Semin Nucl Med; 2001 Jan; 31(1):28-49. PubMed ID: 11200203
[TBL] [Abstract][Full Text] [Related]
6. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
7. Skeletal PET with 18F-fluoride: applying new technology to an old tracer.
Grant FD; Fahey FH; Packard AB; Davis RT; Alavi A; Treves ST
J Nucl Med; 2008 Jan; 49(1):68-78. PubMed ID: 18077529
[TBL] [Abstract][Full Text] [Related]
8. [Bone scanning with sodium 18F-fluoride PET and PET/CT. German guideline Version 1.0.].
Hellwig D; Krause BJ; Schirrmeister H; Freesmeyer M
Nuklearmedizin; 2010; 49(5):195-201. PubMed ID: 20838734
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
11. [Combining CT and scintigraphy: SPECT-CT and PET-CT].
Vöö S; van Dongen TM; Waterval JJ; Willems P; Mottaghy F; Brans B
Ned Tijdschr Geneeskd; 2011; 155(36):A2792. PubMed ID: 21914229
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
[TBL] [Abstract][Full Text] [Related]
13. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
14. Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis.
Ng QKT; Sethi P; Saunders TA; Pampaloni MH; Flavell RR
Clin Nucl Med; 2018 Mar; 43(3):e89-e92. PubMed ID: 29261619
[TBL] [
